Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Z-Wave SmartStart and S2 Security—Together at Last November 1, 2017 Honda and GM Partnering on Next Gen Battery June 28, 2018 WhatsApp privacy policy: SC Constitution bench to hear on Monday May 13, 2017